Plimoth Trust Co. LLC Increases Stock Position in Cigna Group $CI

Plimoth Trust Co. LLC increased its holdings in Cigna Group (NYSE:CI) by 4.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,693 shares of the health services provider’s stock after buying an additional 217 shares during the period. Plimoth Trust Co. LLC’s holdings in Cigna Group were worth $1,551,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Modern Wealth Management LLC raised its stake in shares of Cigna Group by 91.3% during the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock valued at $1,030,000 after purchasing an additional 1,494 shares during the period. Janney Montgomery Scott LLC increased its position in shares of Cigna Group by 3.9% during the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after buying an additional 1,357 shares during the period. Acadian Asset Management LLC lifted its holdings in shares of Cigna Group by 277.5% in the first quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock worth $2,718,000 after buying an additional 6,082 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Cigna Group in the first quarter worth about $431,000. Finally, NBC Securities Inc. bought a new position in shares of Cigna Group in the first quarter valued at approximately $123,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 4.8%

NYSE CI opened at $311.24 on Monday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock’s 50-day simple moving average is $292.41 and its two-hundred day simple moving average is $309.65. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88. The company has a market capitalization of $83.08 billion, a price-to-earnings ratio of 16.99, a PEG ratio of 0.91 and a beta of 0.45.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the prior year, the business earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 1.9%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CI. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday. Barclays boosted their target price on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a report on Saturday, September 27th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $371.81.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.